Lifespan Edge Opens Longevity Clinics in Florida and Maryland, Expanding Access to Preventive Care

Lifespan Edge, a next-generation longevity clinic co-founded by futurist John Mauldin and preventive medicine pioneer Dr. Michael Roizen, announced the opening of two new locations in West Palm Beach, Florida, and Columbia, Maryland, with a third premier destination planned for Scottsdale, Arizona. The expansion marks a significant step in making personalized, evidence-based longevity care more accessible to a broader population.

Founded in 2024, Lifespan Edge aims to bridge cutting-edge longevity research with individualized clinical care for individuals seeking to optimize healthspan, cognitive vitality, and quality of life. Dr. Michael Roizen, Chair of the Board and Co-Founder, emphasized that healthcare should begin decades before disease appears, focusing on modifiable factors that influence aging through personalized care, lifestyle choices, and scientific advances.

The new locations include a clinic at 2528 Okeechobee Blvd. in West Palm Beach, Florida, and another at 10700 Charter Drive, Suite 200, in Columbia, Maryland. A third location is coming soon to Scottsdale, Arizona, designed as a premier luxury wellness destination for clients across the United States and abroad. Each clinic offers a concierge-style experience with advanced diagnostics, physician-guided evaluations, and personalized strategies focused on prevention, performance, and healthy aging.

Interest in longevity medicine has accelerated as consumers seek proactive approaches to maintaining cognitive function, metabolic health, and physical resilience. Lifespan Edge emphasizes early identification of risk factors and individualized plans rather than treating symptoms after disease onset. John Mauldin, President and Co-Founder, noted that the clinics aim to translate advancing longevity research into practical strategies that empower people to live healthier, more productive lives.

A key area of scientific interest is Therapeutic Plasma Exchange (TPE), a procedure being investigated for potential applications in aging and neurodegenerative disease. Notable research includes the AMBAR (Alzheimer Management by Albumin Replacement) clinical trial, which evaluated plasma exchange with albumin replacement in mild-to-moderate Alzheimer’s disease. Published findings showed promise in slowing decline in cognitive and functional measures, though investigators called for more research to define its role.

Dr. Roizen has long advocated that biological age and chronological age are not always the same, emphasizing that nutrition, physical activity, stress management, purpose, and social connection can meaningfully influence long-term health. He believes prevention should remain the foundation of modern medicine, noting that people have more influence over their future health than they often realize through daily decisions.

With additional locations planned, Lifespan Edge aims to redefine aging by combining physician expertise, advanced diagnostics, and evolving longevity science. The expansion into Florida, Maryland, and soon Arizona represents an important step toward making sophisticated longevity care available to more communities. The company’s leadership has gained national recognition, with Dr. Roizen featured in Entrepreneur and TopDoctor Magazine, where he discussed his vision for longevity science and the importance of empowering individuals to take an active role in their long-term health.

This news story relied on content distributed by Newsworthy.ai. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is Lifespan Edge Opens Longevity Clinics in Florida and Maryland, Expanding Access to Preventive Care.

The post Lifespan Edge Opens Longevity Clinics in Florida and Maryland, Expanding Access to Preventive Care appeared first on citybuzz.